Activation of the PI3K/Akt/mTOR pathway also modulates the CRC immune microenvironment by influencing cellular metabolism, promoting the survival of immunosuppressive cells, and enhancing the secretion of immunoregulatory cytokines and checkpoint molecules [185]. Here, MTOR is linked to colorectal carcinoma.